Article
Omer BenโAharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein
Season 2, Episode 13: Finding A Path Forward with Art Krieg
On this episode of The Pharmaverse Podcast, Art Krieg, the President of Zola Therapeutics, tells Michael that vision, endurance, resilience, and a whole lot of grit are needed to run a biotech.
Krieg has faced the rugged terrain and uphill climbs that come with building science-based companies. But just like a marathoner, he’s never stopped putting one foot in front of the other.
๐ง In this episode, Art and Michael discuss:
โ The parallels between biotech leadership and long-distance running
โ Lessons learned from exits, IPOs, and immuno-oncology breakthroughs
โ Why perseverance and pacing are more important than ever in today’s market
๐๐ ๐ฒ๐จ๐ฎ'๐ซ๐ ๐ ๐ฅ๐๐๐๐๐ซ ๐จ๐ซ ๐๐ง ๐๐ฌ๐ฉ๐ข๐ซ๐ข๐ง๐ ๐๐จ๐ฎ๐ง๐๐๐ซ—๐ญ๐ก๐ข๐ฌ ๐ข๐ฌ ๐๐ง ๐๐ฉ๐ข๐ฌ๐จ๐๐ ๐ฒ๐จ๐ฎ ๐๐จ๐ง’๐ญ ๐ฐ๐๐ง๐ญ ๐ญ๐จ ๐ฆ๐ข๐ฌ๐ฌ.
Related Topics
You May Also Like
Omer BenโAharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein
Press Release
OVN Staff
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
Press Release
OVN Staff
Introducing OncologyVoiceNetwork.com
Article
A. Haslam, M.S. Kim, V. Prasad
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
Podcast
MSL Talk: Tom Caravela, Sarah Snyder
The Ideal Roadmap for New MSLs
Article
B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.